| Literature DB >> 35972956 |
Eva Piano Mortari1,2, Federica Pulvirenti3.
Abstract
During the last 2 years and a half, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide, causing about 6 million deaths. Clinical manifestations are highly variable, ranging from entirely asymptomatic infection to multiorgan failure and death. The outcome in immunocompromised patients is still a matter of debate, and so are the optimal strategies to prevent or treat the infection in these high-risk populations. © Crown copyright 2022.Entities:
Keywords: immunodeficiency diseases; infection; vaccination; virus
Mesh:
Year: 2022 PMID: 35972956 PMCID: PMC9384801 DOI: 10.1093/cei/uxac080
Source DB: PubMed Journal: Clin Exp Immunol ISSN: 0009-9104 Impact factor: 5.732